1.Theoretical Peptide Mass Distribution in the Non-Redundant Protein Database of the NCBI.
Da Jeong LIM ; Hee Seok OH ; Hee Bal KIM
Genomics & Informatics 2006;4(2):65-70
Peptide mass mapping is the matching of experimentally generated peptides masses with the predicted masses of digested proteins contained in a database. To identify proteins by matching their constituent fragment masses to the theoretical peptide masses generated from a protein database, the peptide mass fingerprinting technique is used for the protein identification. Thus, it is important to know the theoretical mass distribution of the database. However, few researches have reported the peptide mass distribution of a database. We analyzed the peptide mass distribution of non-redundant protein sequence database in the NCBI after digestion with 15 different types of enzymes. In order to characterize the peptide mass distribution with different digestion enzymes, a power law distribution (Zipfs law) was applied to the distribution. After constructing simulated digestion of a protein database, rank-frequency plot of peptide fragments was applied to generalize a Zipfs law curve for all enzymes. As a result, our data appear to fit Zipfs law with statistically significant parameter values.
Databases, Protein*
;
Dermatoglyphics
;
Digestion
;
Jurisprudence
;
Peptide Fragments
;
Peptides
2.Polymicrobial peritonitis during CAPD.
Joon Hee WOO ; Kee Up KIM ; Hong Soo KIM ; Dong Chul HAN ; Sang Koo LEE ; Seung Duk HWANG ; Hee Bal LEE
Korean Journal of Infectious Diseases 1993;25(4):343-349
No abstract available.
Peritoneal Dialysis, Continuous Ambulatory*
;
Peritonitis*
3.Effect of Percutaneous Transluminal Angioplasty in insufficiency of Arteriovenous Fistula for Hemodialysis.
Chung Sik CHOI ; Dong Erk GOO ; Kyeung Suk KIM ; Hun Hwa KIM ; Dae Ho KIM ; Deuk Lin CHOI ; Chul MUN ; Hee Bal LEE
Journal of the Korean Radiological Society 1999;40(6):1105-1111
PURPOSE: To evaluate the effectiveness of percutaneous transluminal angioplasty(PTA) and to determine thefactors affecting the long-term patency rate in the management of insufficient hemodialytic arteriovenousfistula(AVF). MATERIALS AND METHODS: Forty-nine cases of insufficient hemodialytic AVF were treated in 44patients(native AVF:20, graft AVF:29, M:17, F:27, Age:22-70 years). In 28 thrombus patients, thrombolysis wasperformed with urokinase, and was followed by PTA. The initial success rate and complications of PTA wereevaluated. According to the site and length of the stenosis, type and age of the AVF, the presence or abscence of thrombus, a history of diabetic mellitus, the patient 's age, and the duration of renal failure, patency rateswere compared within each subgroup using the Kaplan-Meier logrank test. RESULTS: The initial success rate of PTAfor insufficient hemodialytic AVF was 88%(43/49), the patency rate of PTA was 67% at 6 months, and 50% at 12months. The initial success rate of thrombolysis was 89%(25/28). The complication rate of PTA was 12%(6/49), ofwhich five cases were vein rupture, and one was subcutaneous hematoma. Statistically, the patency rates in theabove mentioned subgroups were not significantly different. CONCLUSION: PTA with or without thrombolysis offerssafe and effective management of insufficient hemodialytic AVF.
Angioplasty*
;
Arteriovenous Fistula*
;
Constriction, Pathologic
;
Hematoma
;
Humans
;
Renal Dialysis*
;
Renal Insufficiency
;
Rupture
;
Thrombosis
;
Transplants
;
Urokinase-Type Plasminogen Activator
;
Veins